CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 163 enrolled
Drug / intervention
Novexdrug
Likely dose
Novex 550mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04146103
NCT04146103N/ACompleted
CompareCT.gov

Prospective Multicenter Open-label One Arm Trial Investigating a Pumpkin Seed, Isoflavonoid and Cranberry Mix in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia

Saint-Joseph University·interventional·Posted Oct 31, 2019·Updated Oct 31, 2019

In Brief

A clinical study evaluating Novex for Benign Prostatic Hyperplasia. Completed, enrolled 163 participants across 1 site.

Detailed Summary

The aim is to assess the efficacy of a mix of Pumpkin Seed Extract, Soy Germ Isoflavonoids and Cranberry (Novex®) in the management of mild to moderate LUTS in BPH patients. The patients will be evaluated based on the severity of LUTS, urological quality of life, and erectile function.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBenign Prostatic Hyperplasia
CountriesLebanon
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 31, 2019
Enrollment StartApr 1, 2018
Primary CompletionJan 31, 2019
Study CompletionMar 31, 2019
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 6.7 years ago

Interventions

Novexdrug

Novex® made of Pumpkin Seed Extract 550mg, Soy Germ Isoflavonoids 50 mg and Cranberry 50mg. The dose is 2 tablets/day taken orally.